Urinary incontinence during treatment with depot phenothiazines.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010640:Phenothiazines; D014549:Urinary Incontinence / Q000139:chemically induced*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010276:Parasympatholytics; D010640:Phenothiazines